BIO Protocol is designed to empower global communities of scientists, patients, and investors to collaboratively fund, develop, and co-own innovative drugs and therapeutics. By utilizing a network of Biotech Decentralized Autonomous Organizations (BioDAOs), the protocol addresses significant gaps in traditional scientific funding, particularly in niche areas such as rare diseases, longevity research, and emerging health issues. The BIO token serves as a crucial component of the decentralized science (DeSci) economy. As a governance token, it allows holders to express their support for specific BioDAOs and provides access to exclusive initial funding rounds. This structure fosters a more inclusive and transparent funding environment, enabling stakeholders to actively participate in the development of groundbreaking medical solutions. With its focus on community-driven initiatives, BIO Protocol aims to create a collaborative ecosystem that bridges the gap between scientific innovation and funding. By leveraging the strengths of its diverse participants, the protocol seeks to accelerate advancements in healthcare and therapeutics. In summary, BIO Protocol not only facilitates the funding of vital health projects but also fosters a sense of ownership among its community members, driving a new era of collaborative drug development. The BIO token is central to this mission, enabling active participation in the governance and funding processes within the ecosystem.